We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Danish pharmaceutical company Novo Nordisk A/S (NOVO-B.KO) said Tuesday it has entered a development and licensing agreement with U.S.-based Emisphere Technologies Inc. (EMIS) to develop and and...
TARRYTOWN, N.Y., March 12 /PRNewswire-FirstCall/ -- Emisphere Technologies, Inc. ("Emisphere," Nasdaq: EMIS) announced today an addendum to its fourth quarter and year ended 2006 financial...
TARRYTOWN, N.Y., Jan. 16 /PRNewswire-FirstCall/ -- Emisphere Technologies, Inc. ("Emisphere", Nasdaq: EMIS) today announced that Michael M. Goldberg, M.D. Emisphere's Chief Executive Officer...
Company to Present Results Today During Presentation at Rodman and Renshaw Healthcare Conference TARRYTOWN, N.Y., Nov. 8 /PRNewswire-FirstCall/ -- Emisphere Technologies, Inc. ("Emisphere...
No Further Toxicology Studies are Planned for the NDA Submission of Oral Calcitonin TARRYTOWN, N.Y., May 25 /PRNewswire-FirstCall/ -- Emisphere Technologies, Inc. ("Emisphere", Nasdaq: EMIS...
Novartis Pharma AG elects to develop oral growth hormone using Emisphere's technology TARRYTOWN, N.Y., May 1 /PRNewswire-FirstCall/ -- Emisphere Technologies, Inc. ("Emisphere", Nasdaq: EMIS...
Emisphere Technologies to Hold Annual Shareholders Meeting on May 23, 2005 TARRYTOWN, N.Y., May 13 /PRNewswire-FirstCall/ -- Emisphere Technologies, Inc. will host its annual shareholders...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions